2004 drug approval highlights: FDA update.
Gary Laustsen, Lynn Wimmett
Journal: The Nurse practitioner
2005;30(2):14-29; quiz 29-31
PMID: 15702013
Address:
Regis University, Denver, CO, USA.
Link outs
Subscription / membership required
MeSH Terms:
Administration, Cutaneous ,
Amlodipine ,
Anti-Bacterial Agents ,
Antidepressive Agents ,
Bronchodilator Agents ,
Cardiovascular Agents ,
Drug Approval ,
Drug Combinations ,
Duloxetine Hydrochloride ,
Eplerenone ,
Estradiol ,
Excitatory Amino Acid Antagonists ,
Female ,
Gastrointestinal Agents ,
Heptanoic Acids ,
Humans ,
Ketolides ,
Male ,
Memantine ,
Osteoporosis, Postmenopausal ,
Pyrroles ,
Rifamycins ,
Rifaximin ,
Scopolamine Derivatives ,
Spironolactone ,
Thiophenes ,
Tiotropium Bromide ,
United States
© Copyright 2026, Nutrition Evidence
NED wishes to thank the following organisations for their support:
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more .
Accept